Industry / Malawi
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Free ARV Access Reduces HIV/AIDS Mortality
May 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
A study of mortality before and after the introduction of free antiretroviral (ARV) therapy in Malawi provides a quantitative insight into the benefit of HIV/AIDS treatment with ARVs. Published in The Lancet medical journal, the paper identifies the population effects of the decision to make ARV therapy free to HIV/AIDS patients in Malawi. A significant drop in mortality after the introduction of free ARV treatment was observed, offering support for the scaling up of ARV provision across